Journal Article

BFAST but be smart: bTMB remains an exploratory biomarker in NSCLC

Nature Reviews Clinical Oncology (2023) 20(1) 3-4
DOI: 10.1038/s41571-022-00698-y
5Citations
Citations of this article
7Readers
Mendeley users who have this article in their library.
Get full text

Cite

CITATION STYLE

APA

Kim, S. Y., & Herbst, R. S. (2023). BFAST but be smart: bTMB remains an exploratory biomarker in NSCLC. Nature Reviews Clinical Oncology, 20(1), 3–4. https://doi.org/10.1038/s41571-022-00698-y

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free